SCHEMBL22790262

SCHEMBL22790262

O=C(O)c1ccc2cc(N3CCNCC3)ccc2n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 2/20 0.51
HTR3B O95264 2/20 0.51
HTR3A P46098 2/20 0.51
HTR3D Q70Z44 2/20 0.51
HTR3C Q8WXA8 2/20 0.51
HTR5A P47898 1/20 0.51
SIGMAR1 Q99720 1/20 0.51
ABL1 P00519 1/20 0.46
HTR1A P08908 1/20 0.45
HTR1D P28221 1/20 0.45
HTR1B P28222 1/20 0.45
ALDH1A1 P00352 3/20 0.45
LMNA P02545 1/20 0.45
PMP22 Q01453 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
HSD17B10 Q99714 2/20 0.44
USP2 O75604 1/20 0.44
TSHR P16473 1/20 0.44
HDAC3 O15379 3/20 0.44
KCNH2 Q12809 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9837631 0.90 HTR3E (0.49) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL28967964 0.87 TERT (0.50) ABL1ALDH1A1HSD17B10TSHRMGAM
SCHEMBL30301247 0.87 TERT (0.50) ABL1ALDH1A1HSD17B10TSHRMGAM
SCHEMBL30074960 0.84 HTR1A (0.50) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL21979979 0.80 HTR3E (0.57) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL22790122 0.79 RAD52 (0.43) KCNH2SCN9ASCN7AMGAMSLC6A4
SCHEMBL20582304 0.77 HTR3E (0.57) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL6948711 0.77 HTR3E (0.57) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL17420335 0.77 TERT (0.56) ABL1ALDH1A1LMNAHSD17B10TSHR
SCHEMBL17420285 0.77 TERT (0.60) ABL1ALDH1A1LMNAHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020249064-A1 COMPOUNDS FOR MODULATING FXR NANJING RUIJIE PHARMA CO., LTD. (CN) 2020-12-17 WO disclosed